A prototype web portal shows technology’s potential to protect and streamline...
A prototype web portal shows technology’s potential to protect and streamline the clinical trials process.

Blockchain could esure integrity of clinical trial data

UC San Francisco researchers have created a proof-of-concept method for ensuring the integrity of clinical trials data with blockchain. The system creates an immutable audit trail that makes it easy to spot any tampering with results – such as making the treatment look more effective or diminishing side effects.

 “Everyone is talking about how blockchain is going to revolutionize many of the data challenges in medicine, and here is one use that finally might make sense,” said Atul Butte, MD, PhD, who is the Priscilla Chan and Mark Zuckerberg Distinguished Professor and director of the Bakar Computational Health Sciences Institute at UCSF. “We think it could someday be useful for pharma companies running clinical trials.”

Blockchain technology utilizes an old computer science technique known as hashing, which creates a unique digital signature for each so-called block of data. The hashes accumulate sequentially, as new data is entered or changed, with each block depending on the last. The resulting “blockchain” creates an audit trail for regulators that is easy to decipher and validate, even without looking at the actual data.

Daniel Wong, a PhD candidate in Biological and Medical Informatics at UCSF, built the system to operate through a web portal, so that each time new data is entered on a given trial participant, the sender, receiver, timestamp, and file attachment containing the data, along with the hash of the previous block of data pertaining to that patient, is recorded onto a new block, with its own distinct signature.

Unlike the decentralized nature of most blockchain applications, this clinical trial prototype depends on having a regulator with centralized authority, such as the FDA, to operate the web portal, register all parties, and keep a ledger of the blockchain’s hashes.

Reduced risks

Data, including adverse events, would be reported to the regulatory agency in real time, which may provide a boost to the safety and efficiency of clinical trials. While the prototype makes allowances for data entry or other errors to be corrected, new data can only be appended to the existing chain, without erasing what was there before. “It makes it really obvious when someone’s changing something,” Wong said. “You can see who put their hands on it, who made it, who changed it, and who received it.”

Wong tested the system with a small subset of data from a real, previously run phase II trial included in ImmPort, a repository of open clinical trial data funded by the National Institutes of Allergy and Infectious Diseases (NIAID) that is managed by Butte’s lab and collaborators.

After entering the original data, he logged in as the trial sponsor and tried to erase adverse events that had been reported for two patients in their case report forms. Instead of deleting those reports, however, the system appended his changes to the original data, making it clear who had tried to corrupt the forms, when it was done, and what had been changed.

Wong also tried corrupting the data stored from an earlier point in the trial, when patients were assigned to different treatment arms – drug or placebo – to make it look as though they had been given a different medication plan. But the blockchain ledger pinpointed exactly what had changed and when.

A prototype system like this reduces risks, but does not completely protect data from tampering. Even within a system enabled with this type of blockchain technology, the authors pointed out, it is still possible that those seeing patients at the point of care could enter wrong or incorrect data at the outset.

But blockchain technology could enable trials to be conducted under challenging conditions, or open doors to data exchanges that are more secure, more efficient, and more transparent for both researchers and the general public. “A system built upon our prototype could be developed to enable oversight of international clinical trials, for example,” Butte said. “And it could be expanded to provide more access to raw data for research scientists, the way we do with ImmPort, or deliver trial results to the public.”

Subscribe to our newsletter

Related articles

A-Medicare will launch new crypto coin

A-Medicare will launch new crypto coin

A-Medicare announced launch plans for a new crypto coin as a planned element of early strategic growth integral to platform development through the remainder of 2020 and 2021.

Tracking prescription drugs via blockchain

Tracking prescription drugs via blockchain

Using blockchain, the US pharmaceutical industry plans track legal changes of ownership of prescription drugs as they move through the supply chain.

Blockchain makes sharing of medical records secure

Blockchain makes sharing of medical records secure

Engineers have successfully developed and validated the feasibility of blockchain-based technologies for secure, confidential sharing of patient medical records.

Blockchain – paradigm shift towards patient-centered healthcare

Blockchain – paradigm shift towards patient-centered healthcare

The use of blockchain will change paradigm towards patient-centered healthcare.

Transactions, trust and tokens – Blockchain for healthcare

Transactions, trust and tokens – Blockchain for healthcare

“A central pillar of blockchain is trust, because data cannot be altered,” says Dr Eberhard Scheuer, Chairman of the Health Information Traceability Foundation.

Blockchain could provide secure communications for robots

Blockchain could provide secure communications for robots

The use of blockchain technology as a communication tool for a team of robots could provide security and safeguard against deception.

How blockchain can help the homeless

How blockchain can help the homeless

Researchers say new technology solutions such as blockchain can be used to keep important health care information of homeless people secure and portable.

Cloud vs.edge computing: rethinking healthcare infrastructure

Cloud vs.edge computing: rethinking healthcare infrastructure

Newer concepts like edge computing are regularly discussed alongside the cloud within the healthcare sector, often as if they are each exclusive approaches to infrastructure. However, using one does not eradicate the ability to utilise the other.

Blockchain may improve the medications of the future

Blockchain may improve the medications of the future

Using blockchain, researchers have developed a prototype of an app that may potentially prescribe the optimal dose of medicine for the individual patient, as well as prevent counterfeit products.

Popular articles

Subscribe to Newsletter